Kodak shares rose nearly 1,500% on COVID drug loan deal.

$Eastman Kodak (KODK.US)$ Shares have surged 1,481% this week in heavy trading as the Trump administration discusses the former photography industry leader a financial lifeline to make ingredients in drugs used to Fight coronavirus.

The company's valuation jumped from $92m to $1.5bn as it shares rose from $2.10 at Friday's close to $33.20 on Wednesday.

The Pandemic, of Course, has played a role printing sales declines. But pivoting to new business lines, especially those backed (and backstopped?) by the U.S. Government could be both lifeline and rejuvenator.